Meningitis Diagnosis & Treatment Market By Type (Fungal, Viral and Bacterial), By Diagnostic Test (Lateral Flow Assay, PCR Assay, Latex Agglutination Tests, Elisa Tests and Culture Tests), By End-User (Hospitals, Clinics and Others), and By Region - Market Trends, Analysis, and Forecast Till 2030

Meningitis Diagnosis and Treatment Market accounted for USD 126.6 Million in 2020 and is estimated to be USD 192.9 Million by 2030 and is anticipated to register a CAGR of 4.3%.

The inflammation of the meninges is known as meningitis. The three membranes that protect the brain and spinal cord are known as the meninges. When the fluid covering the meninges becomes infected, meningitis may develop. Viruses, fungi, and bacteria are the most common causes of meningitis. If left untreated, the disease can be fatal, so prompt treatment is needed to keep it under control. Each form of meningitis has a different cause, but they all have the same symptoms.. Noninfectious meningitis is caused by a physical injury or another disease rather than an infection. HIV, tuberculosis, and some illnesses may also cause meningitis.

Rising initiatives by government bodies

Meningitis is a fatal and incapacitating disease that strikes suddenly, has severe health, economic, and social effects, and affects people of all ages in all countries. Bacterial meningitis has the potential to spread epidemics, cause death within 24 hours, and leave one out of every five patients disabled for the rest of their lives. Meningitis is vaccine preventable in many cases and deaths, but success in eradicating the disease lags behind other vaccine-preventable diseases. Governments, global health agencies, public health organisations, academia, the private sector, and civil society leaders all called for a global vision to eliminate meningitis as a public health problem in 2017. The WHO responded to the call to action by developing a road map to eliminate meningitis by 2030 in collaboration with partners and experts involved in the disease's prevention and control. Throughout 2019, there were several public and expert consultations.

Growth in business operations by emerging and small sized players

The growing prevalence of meningitis as well as increased efforts to tackle the disease, such as efforts to minimize the disease's incidence and better control the disease are driving the meningitis diagnosis and treatment market. Over the forecast period, growing demand for point-of-care diagnostic services, especially for chronic diseases, is expected to be a major driver of the meningitis diagnosis and treatment market. Growing investments in R&D for effective diagnosis and treatment of such a critical disease, as well as an increase in the number of cases of meningitis, are expected to propel the market forward. Other factors driving market growth include the introduction of new technologies and products, as well as the continued expansion of the medical device industry.

Meningitis Diagnosis and treatment market is segmented based on type, diagnostic tests, end-user and region.

On the basis of type, the Meningitis diagnosis and treatment market is segmented into fungal bacterial and viral. Based on Diagnostics tests, the target market is segmented into lateral flow assay, PCR assay, latex agglutination tests, ELISA tests and culture tests. On the basis of end-user, the target market is segmented into hospitals, clinics and others.

Regional Insights:

On region the meningitis diagnosis and treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market for meningitis diagnosis and care, with the largest market shares. The demand in North America is expected to rise due to a fast adoption rate of advanced medical devices, easy availability of diagnostic test kits, and a high number of cases of viral meningitis.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2030. For the purpose of this study, has segmented the meningitis diagnosis and treatment market report based on type, diagnostic test, end-user, and region.

Meningitis Diagnosis and Treatment Market, By Region:

• North America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • U.S.
  • Canada

The key players operating in the meningitis diagnosis and treatment market includes Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Nanosphere (Luminex Corporation), Seegene Inc., Qnostics, ELITechGroup, and Abbott Laboratories. To meet the needs of their customers, these industry leaders are launching new goods. To broaden their customer base and strengthen their market presence, players are entering new markets in emerging regions.

• Thermo Fisher Scientific, Inc
• Fast Track diagnostic ltd.
• Siemens Healthineers
• Bio-Rad laboratories Inc.
• IMMY
• BioFire Diagnostics
• Nanosphere (Luminex Corporation)
• Seegene Inc.
• Qnostics
• ELITechGroup
• Abbott Laboratories